Histone deacetylases inhibitors (HDACis) as novel therapeutic application in various clinical diseases

被引：68

作者：

Qiu, Xiaoyan ^{[1
]}

Xiao, Xiong ^{[1
]}

Li, Nan ^{[1
]}

Li, Yuemin ^{[1
]}

机构：

[1] Southwest Univ, Sch Anim Sci & Technol, 2 Tian Sheng St, Chongqing 400715, Peoples R China

来源：

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 2017年 / 72卷

基金：

中国国家自然科学基金;

关键词：

HDACi; Brain disorders; Cancer; Endometriosis; Cell reprogramming; SUBEROYLANILIDE HYDROXAMIC ACID; SPINAL MUSCULAR-ATROPHY; CELL NUCLEAR TRANSFER; RUBINSTEIN-TAYBI-SYNDROME; IN-VITRO DEVELOPMENT; EXPERIMENTALLY-INDUCED ENDOMETRIOSIS; TRANSGENIC MOUSE MODEL; LONG-TERM-MEMORY; PHASE-II TRIAL; PROTECTS DOPAMINERGIC-NEURONS;

D O I：

10.1016/j.pnpbp.2016.09.002

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Accumulating evidence suggests that histone hypoacetylation which is partly mediated by histone deacetylase (HDAC), plays a causative role in the etiology of various clinical disorders such as cancer and central nervous diseases. HDAC inhibitors (HDACis) are natural or synthetic small molecules that can inhibit the activities of HDACs and restore or increase the level of histone acetylation, thus may represent the potential approach to treating a number of clinical disorders. This manuscript reviewed the progress of the most recent experimental application of HDACis as novel potential drugs or agents in a large number of clinical disorders including various brain disorders including neurodegenerative and neurodevelopmental cognitive disorders and psychiatric diseases like depression, anxiety, fear and schizophrenia, and cancer, endometriosis and cell reprogramming in somatic cell nuclear transfer in human and animal models of disease, and concluded that HDACis as potential novel therapeutic agents could be used alone or in adjunct to other pharmacological agents in various clinical diseases. (C) 2016 Elsevier Inc. All rights reserved.

引用

页码：60 / 72

页数：13

共 283 条

[21] Apicidin and Docetaxel Combination Treatment Drives CTCFL Expression and HMGB1 Release Acting as Potential Antitumor Immune Response Inducers in Metastatic Breast Cancer Cells [J].

Buoncervello, Maria ;

Borghi, Paola ;

Romagnoli, Giulia ;

Spadaro, Francesca ;

Belardelli, Filippo ;

Toschi, Elena ;

Gabriele, Lucia .

NEOPLASIA, 2012, 14 (09) :855-U112

[22] Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia [J].

Casey, DE ;

Daniel, DG ;

Wassef, AA ;

Tracy, KA ;

Wozniak, P ;

Sommerville, KW .

NEUROPSYCHOPHARMACOLOGY, 2003, 28 (01) :182-192

[23] Suberoylanilide Hydroxamic Acid (Vorinostat) Up-regulates Progranulin Transcription RATIONAL THERAPEUTIC APPROACH TO FRONTOTEMPORAL DEMENTIA [J].

Cenik, Basar ;

Sephton, Chantelle F. ;

Dewey, Colleen M. ;

Xian, Xunde ;

Wei, Shuguang ;

Yu, Kimberley ;

Niu, Wenze ;

Coppola, Giovanni ;

Coughlin, Sarah E. ;

Lee, Suzee E. ;

Dries, Daniel R. ;

Almeida, Sandra ;

Geschwind, Daniel H. ;

Gao, Fen-Biao ;

Miller, Bruce L. ;

Farese, Robert V., Jr. ;

Posner, Bruce A. ;

Yu, Gang ;

Herz, Joachim .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (18) :16101-16108

[24] The forced swimming-induced behavioural immobility response involves histone H3 phospho-acetylation and c-Fos induction in dentate gyrus granule neurons via activation of the N-methyl-D-aspartate/extracellular signal-regulated kinase/mitogen- and stress-activated kinase signalling pathway [J].

Chandramohan, Yalini ;

Droste, Susanne K. ;

Arthur, J. Simon C. ;

Reul, Johannes M. H. M. .

EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 27 (10) :2701-2713

[25] Treatment of spinal muscular atrophy by sodium butyrate [J].

Chang, JG ;

Hsieh-Li, HM ;

Jong, YJ ;

Wang, NM ;

Tsai, CH ;

Li, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (17) :9808-9813

[26] Potentiation of sodium butyrate-induced apoptosis by vanadate in human promyelocytic leukemia cell line HL-60 [J].

Chang, ST ;

Yung, BYM .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 221 (03) :594-601

[27] Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes [J].

Chen, P-S ;

Peng, G-S ;

Li, G. ;

Yang, S. ;

Wu, X. ;

Wang, C-C ;

Wilson, B. ;

Lu, R-B ;

Gean, P-W ;

Chuang, D-M ;

Hong, J-S .

MOLECULAR PSYCHIATRY, 2006, 11 (12) :1116-1125

[28] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage [J].

Chen, S. H. ;

Wu, H. M. ;

Ossola, B. ;

Schendzielorz, N. ;

Wilson, B. C. ;

Chu, C. H. ;

Chen, S. L. ;

Wang, Q. ;

Zhang, D. ;

Qian, L. ;

Li, X. ;

Hong, J. S. ;

Lu, R. B. .

BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (02) :494-505

[29] On the epigenetic regulation of the human reelin promoter [J].

Chen, Y ;

Sharma, RP ;

Costa, RH ;

Costa, E ;

Grayson, DR .

NUCLEIC ACIDS RESEARCH, 2002, 30 (13) :2930-2939

[30] In vitro reactivation of the FMR1 gene involved in fragile X syndrome [J].

Chiurazzi, P ;

Pomponi, MG ;

Willemsen, R ;

Oostra, BA ;

Neri, G .

HUMAN MOLECULAR GENETICS, 1998, 7 (01) :109-113

← 1 2 3 4 5 6 7 8 9 10 →